Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.57%
After-hours: Aug 15, 2025, 07:58 PM EDT

Capricor Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
n/a -24.39M -7.12M -12.56M -11M -9.79M -762.09K -6.39M -7.37M -7.77M -7.72M -6.37M -7.11M -7.82M -6.19M -3.93M -4.75M -5.15M
Depreciation & Amortization
233.49M 405.45K 375.7K 361.17K 356.94K 331.41K 307.61K 276.47K 254.7K 230.1K 191.6K 137.03K 112.01K 92.49K 78.64K 64.72K 52.2K 50.14K
Stock-Based Compensation
7.51B 5.74M 2.3M 2.05M 2.15M 3.27M 1.86M 1.72M 1.62M 2.19M 1.15M 1.09M 1.16M 1.07M 780.15K 720.28K 712.3K 752.96K
Other Working Capital
n/a 55.47K -2.15M -10.23B -3.79M -5.06M -2.63M -6.06M -3.63M -562.77M -550.27K -1.28M -545.79K 30.55M -433.49K -191.12K -212.51K -743.58M
Other Non-Cash Items
-7.74B 133.83K 96.48K -347.63K -10.1K -6.08M 12.83M -1.02K -6.45K -6.45K 27.75K 22.79K -12.62K 158.09K -13.38M 1.22M -318.16K 108.63K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.84M 5.39K n/a n/a n/a n/a n/a n/a 13.52M n/a n/a n/a
Change in Working Capital
n/a 11.68M -10.45M -1.15M -3.79M 4.94M -12.99M -4.4M -3.92M 9.56M -548.71K -561.44K -690.15K 30.55M -433.49K -191.12K -212.51K 1.02M
Operating Cash Flow
n/a -6.43M -14.8M -11.64M -12.29M -1.27M -11.59M -8.79M -9.42M 4.21M -6.9M -5.69M -6.54M 24.05M -5.63M -3.34M -4.51M -3.33M
Capital Expenditures
n/a -1.14M -734.72K -59.03K -80.91K -664.32K -729.22K -631.75K -233.44K -453.12K -1.22M -1.1M -412.56K -625.36K -368.67K -468.24K -322.46K -36.91K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 5.13M -8.35M -6.69M 105.42M 1.36B 3.08M 35M n/a n/a n/a n/a n/a
Purchase of Investments
n/a -18.18M -139.36M -69.03B -16.07M -33.21M -24.78M -19.8M -18.06M -34.8M -32.04M -33.16M -49.01M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 43.21M 16.72M 21.86M 30.85M 24.37M 19.64M 28.16M 24.75M 32.05M 38.41M 30.09M 14.01M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 69.69B n/a -55.73M -5.13M 8.35M 6.69M -105.42M -1.36B -3.08M -35M -57.74M n/a n/a n/a n/a
Investing Cash Flow
n/a 23.89M -123.38M 2M 14.7M -9.5M -5.86M 7.72M 6.46M -3.21M 5.14M -4.18M -35.41M -625.36K -368.67K -468.24K -322.46K -36.91K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 121K 81.22K n/a 3.03K n/a 57.68K 3.9K 26.32K 1.52K 15.01K 27.46K 42.37K 5.21K n/a 1.44K
Financial Cash Flow
n/a 50.35K 81.09M 67.33M 2.07M 2.29M 23.17M 221.08K 2.19M 3.9K 2.95M 1.88M 15.01K 27.46K 42.37K 6.57M 1.04M 12.58M
Net Cash Flow
n/a 17.51M -57.09M 57.69M 4.47M -8.48M 5.71M -852.47K -768.39K 1M 1.19M -7.98M -41.94M 23.45M -5.95M 2.76M -3.8M 9.21M
Free Cash Flow
n/a -7.57M -15.53M -11.7M -12.37M -1.93M -12.32M -9.43M -9.65M 3.76M -8.12M -6.78M -6.95M 23.42M -6M -3.81M -4.84M -3.37M